Clinical Trial

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-13; most recent amendment 2026-04-26.
Status change: Not Yet Recruiting → Recruiting 2025-07-16
Trial Details
NCT Number NCT06983366
Lead Sponsor Assiut University
Collaborators: Aliae AR Mohamed Hussein [ahussein
Conditions COPD, ILD, Bronchiectasis, Pneumothorax, Pneumonia, Pleural Effusion Disorder, Pulmonary Oedema
Enrollment 700 participants
Start Date 2025-05-30
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-30